Exjade 00078-0468-15
Generic: Deferasirox
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 30, 2005
- Listing Expires
- December 31, 2027
- Application
- NDA021882
Need to source Exjade? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 125 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
00078-0468-15Selected30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0468-15)